Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)

• Үндсэн зохиолчид: Dan Wang (Зохиогч), Yimeng Du (Зохиогч), Wenpeng Zhang (Зохиогч), Xiaolu Han (Зохиогч), Hui Zhang (Зохиогч), Zengming Wang (Зохиогч), Nan Liu (Зохиогч), Meng Li (Зохиогч), Xiang Gao (Зохиогч), Xiaomei Zhuang (Зохиогч), Jing Gao (Зохиогч), Aiping Zheng (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

For efficient intranasal transport of parathyroid hormone (1-34) [PTH(1-34)], there is a great medical need to investigate permeation enhancers for intranasal formulations. In this study, the development of PTH(1-34) intranasal formulations was conducted. Based on conformation and chemical stability...